Cochrane Reviews and Protocols related to Complementary Medicine

Here is a list, in alphabetical order, of the reviews and protocols that we have assessed as related to complementary or integrative medicine, which are currently available in the Cochrane Library.

Cochrane complementary medicine-related reviews as of December 31 2021

  1. Acanthopanax for acute ischaemic stroke
  2. Acetyl‐l‐carnitine for dementia
  3. Acetyl‐L‐carnitine for patients with hepatic encephalopathy
  4. Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
  5. Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
  6. Acupuncture and acupressure for premenstrual syndrome
  7. Acupuncture and assisted reproductive technology
  8. Acupuncture and dry‐needling for low back pain
  9. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis
  10. Acupuncture and related interventions for smoking cessation
  11. Acupuncture and related interventions for symptoms of chronic kidney disease
  12. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome
  13. Acupuncture for acute hordeolum
  14. Acupuncture for acute management and rehabilitation of traumatic brain injury
  15. Acupuncture for acute stroke
  16. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
  17. Acupuncture for autism spectrum disorders (ASD)
  18. Acupuncture for Bell's palsy
  19. Acupuncture for cancer pain in adults
  20. Acupuncture for chronic asthma
  21. Acupuncture for chronic hepatitis B
  22. Acupuncture for chronic nonspecific low back pain
  23. Acupuncture for depression
  24. Acupuncture for dysmenorrhoea
  25. Acupuncture for dysphagia in acute stroke
  26. Acupuncture for epilepsy
  27. Acupuncture for functional dyspepsia
  28. Acupuncture for glaucoma
  29. Acupuncture for hip osteoarthritis
  30. Acupuncture for hypertension
  31. Acupuncture for hypoxic ischemic encephalopathy in neonates
  32. Acupuncture for insomnia
  33. Acupuncture for lateral elbow pain
  34. Acupuncture for menopausal hot flushes
  35. Acupuncture for mumps in children
  36. Acupuncture for neuropathic pain in adults
  37. Acupuncture for pain in endometriosis
  38. Acupuncture for peripheral joint osteoarthritis
  39. Acupuncture for polycystic ovarian syndrome
  40. Acupuncture for restless legs syndrome
  41. Acupuncture for schizophrenia
  42. Acupuncture for shoulder pain
  43. Acupuncture for slowing the progression of myopia in children and adolescents
  44. Acupuncture for stress urinary incontinence in adults
  45. Acupuncture for stroke rehabilitation
  46. Acupuncture for symptomatic gastroparesis
  47. Acupuncture for the prevention of episodic migraine
  48. Acupuncture for the prevention of tension‐type headache
  49. Acupuncture for treating acute ankle sprains in adults
  50. Acupuncture for treating fibromyalgia
  51. Acupuncture for treatment of irritable bowel syndrome
  52. Acupuncture for uterine fibroids
  53. Acupuncture for vascular dementia
  54. Acupuncture or acupressure for induction of labour
  55. Acupuncture or acupressure for pain management during labour
  56. Alcohol intake reduction for controlling hypertension
  57. Alexander technique for chronic asthma
  58. Aloe vera for prevention and treatment of infusion phlebitis
  59. Aloe vera for treating acute and chronic wounds
  60. Alpha lipoic acid for dementia
  61. Altered dietary salt for preventing pre‐eclampsia, and its complications
  62. Altered dietary salt intake for people with chronic kidney disease
  63. Altered dietary salt intake for preventing and treating diabetic kidney disease
  64. Alternating current cranial electrotherapy stimulation (CES) for depression
  65. Animal‐assisted therapy for dementia
  66. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
  67. Antenatal breast milk expression by women with diabetes for improving infant outcomes
  68. Antenatal dietary supplementation with myo‐inositol in women during pregnancy for preventing gestational diabetes
  69. Anti‐spasticity agents for multiple sclerosis
  70. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
  71. Antiemetic medication for prevention and treatment of chemotherapy‐induced nausea and vomiting in childhood
  72. Antioxidant supplementation for lung disease in cystic fibrosis
  73. Antioxidant supplements for liver diseases
  74. Antioxidant supplements for non‐alcoholic fatty liver disease and/or steatohepatitis
  75. Antioxidant supplements for preventing gastrointestinal cancers
  76. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
  77. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
  78. Antioxidant treatments for schizophrenia
  79. Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
  80. Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
  81. Antioxidant vitamin supplementation for preventing and slowing the progression of age‐related cataract
  82. Antioxidants for chronic kidney disease
  83. Antioxidants for female subfertility
  84. Antioxidants for male subfertility
  85. Antioxidants for pain in chronic pancreatitis
  86. Antioxidants for preventing and reducing muscle soreness after exercise
  87. Antioxidants for preventing pre‐eclampsia
  88. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline
  89. Aromatherapy for dementia
  90. Aromatherapy for pain management in labour
  91. Aromatherapy for treatment of postoperative nausea and vomiting
  92. Art therapy for people with dementia
  93. Art therapy for schizophrenia or schizophrenia‐like illnesses
  94. Ascorbic acid for the treatment of Charcot‐Marie‐Tooth disease
  95. Assessment and support during early labour for improving birth outcomes
  96. Assisted reproductive technology: an overview of Cochrane Reviews
  97. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
  98. Auricular acupuncture for cocaine dependence
  99. Ayurvedic medicine for schizophrenia
  100. Ayurvedic treatments for diabetes mellitus
  101. Balneotherapy (or spa therapy) for rheumatoid arthritis
  102. Balneotherapy for chronic venous insufficiency
  103. Balneotherapy for osteoarthritis
  104. Behavioural interventions for dysmenorrhoea
  105. Behavioural interventions for smoking cessation: an overview and network meta‐analysis
  106. Behavioural therapies versus other psychological therapies for depression
  107. Behavioural treatment for chronic low‐back pain
  108. Beta‐sitosterols for benign prostatic hyperplasia
  109. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults
  110. Biofeedback for pain management during labour
  111. Biofeedback for treatment of chronic idiopathic constipation in adults
  112. Biofeedback for treatment of irritable bowel syndrome
  113. Black cohosh (Cimicifuga spp.) for menopausal symptoms
  114. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
  115. Branched‐chain amino acids for people with hepatic encephalopathy
  116. Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour
  117. Breathing exercises for adults with asthma
  118. Bright light therapy for sleep problems in adults aged 60+
  119. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
  120. Caffeine as an analgesic adjuvant for acute pain in adults
  121. Caffeine for asthma
  122. Caffeine for the prevention of injuries and errors in shift workers
  123. Calcium and vitamin D for corticosteroid‐induced osteoporosis
  124. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
  125. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
  126. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
  127. Calcium supplementation for improving bone mineral density in children
  128. Calcium supplementation for prevention of primary hypertension
  129. Calcium supplementation for the management of primary hypertension in adults
  130. Calcium, vitamin D or recombinant parathyroid hormone for managing post‐thyroidectomy hypoparathyroidism
  131. Calorie controlled diet for chronic asthma
  132. Cannabinoids for epilepsy
  133. Cannabinoids for fibromyalgia
  134. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
  135. Cannabinoids for the treatment of dementia
  136. Cannabinoids for the treatment of dementia
  137. Cannabinoids for Tourette's Syndrome
  138. Cannabis and schizophrenia
  139. Cannabis for the treatment of Crohn's disease
  140. Cannabis for the treatment of ulcerative colitis
  141. Cannabis‐based medicines for chronic neuropathic pain in adults
  142. Capsaicin for non‐allergic rhinitis
  143. Cardioprotective interventions for cancer patients receiving anthracyclines
  144. Carnitine for fatigue in multiple sclerosis
  145. Carnitine supplementation for inborn errors of metabolism
  146. Castor oil, bath and/or enema for cervical priming and induction of labour
  147. Cephalic version by moxibustion for breech presentation
  148. Chelation for autism spectrum disorder (ASD)
  149. Chelation therapy for atherosclerotic cardiovascular disease
  150. Chinese herbal medicine for atopic eczema
  151. Chinese herbal medicine for chronic neck pain due to cervical degenerative disc disease
  152. Chinese herbal medicine for diabetic peripheral neuropathy
  153. Chinese herbal medicine for endometriosis
  154. Chinese herbal medicine for menopausal symptoms
  155. Chinese herbal medicine for oesophageal cancer
  156. Chinese herbal medicine for premenstrual syndrome
  157. Chinese herbal medicine for primary dysmenorrhoea
  158. Chinese herbal medicine for schizophrenia
  159. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
  160. Chinese herbal medicine for treating recurrent urinary tract infections in women
  161. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
  162. Chinese herbal medicine in the treatment of ectopic pregnancy
  163. Chinese herbal medicine suxiao jiuxin wan for angina pectoris
  164. Chinese herbal medicines for acute pancreatitis
  165. Chinese herbal medicines for benign thyroid nodules in adults
  166. Chinese herbal medicines for hypercholesterolemia
  167. Chinese herbal medicines for hyperthyroidism
  168. Chinese herbal medicines for hypertriglyceridaemia
  169. Chinese herbal medicines for hypothyroidism
  170. Chinese herbal medicines for induction of remission in advanced or late gastric cancer
  171. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
  172. Chinese herbal medicines for threatened miscarriage
  173. Chinese herbal medicines for treating osteoporosis
  174. Chinese herbal medicines for treating pre‐eclampsia
  175. Chinese herbal medicines for treating skin and soft‐tissue infections
  176. Chinese herbal medicines for type 2 diabetes mellitus
  177. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
  178. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
  179. Chinese medicinal herbs for acute bronchitis
  180. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
  181. Chinese medicinal herbs for cholelithiasis
  182. Chinese medicinal herbs for chronic hepatitis B
  183. Chinese medicinal herbs for influenza
  184. Chinese medicinal herbs for measles
  185. Chinese medicinal herbs for mumps
  186. Chinese medicinal herbs for sore throat
  187. Chinese medicinal herbs for the common cold
  188. Chitosan for overweight or obesity
  189. Chondroitin for osteoarthritis
  190. Chromium picolinate supplementation for overweight or obese adults
  191. Chuanxiong‐type preparations for acute ischemic stroke
  192. Cinnamon for diabetes mellitus
  193. Co‐enzyme Q10 supplementation for the primary prevention of cardiovascular disease
  194. Coenzyme Q10 for heart failure
  195. Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
  196. Cognitive behavioural therapy for tinnitus
  197. Cold‐water immersion (cryotherapy) for preventing and treating muscle soreness after exercise
  198. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
  199. Combined chiropractic interventions for low‐back pain
  200. Combined diet and exercise interventions for preventing gestational diabetes mellitus
  201. Combined vitamin B6‐magnesium treatment in autism spectrum disorder
  202. Complementary and alternative therapies for pain management in labour
  203. Complementary and miscellaneous interventions for nocturnal enuresis in children
  204. Complementary therapies for acne vulgaris
  205. Conservative interventions for treating exercise‐related musculotendinous, ligamentous and osseous groin pain
  206. Conservative interventions for treating functional daytime urinary incontinence in children
  207. Conservative management for postprostatectomy urinary incontinence
  208. Conservative management of symptomatic and/or complicated haemorrhoids in pregnancy and the puerperium
  209. Continuous support for women during childbirth
  210. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
  211. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
  212. Cranberries for preventing urinary tract infections
  213. Cranberries for treating urinary tract infections
  214. Creatine for amyotrophic lateral sclerosis/motor neuron disease
  215. Creatine for Parkinson's disease
  216. Creatine for treating muscle disorders
  217. Creatine for women in pregnancy for neuroprotection of the fetus
  218. Curcumin for maintenance of remission in ulcerative colitis
  219. Cyclamen europaeum extract for acute sinusitis
  220. Daily oral iron supplementation during pregnancy
  221. Dan Shen agents for acute ischaemic stroke
  222. Dance movement therapy for dementia
  223. Dance movement therapy for depression
  224. Dance therapy for schizophrenia
  225. Dance/movement therapy for improving psychological and physical outcomes in cancer patients
  226. Danshen (Chinese medicinal herb) preparations for acute myocardial infarction
  227. Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis
  228. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
  229. Dehydroepiandrosterone for systemic lupus erythematosus
  230. Dehydroepiandrosterone for women in the peri‐ or postmenopausal phase
  231. Delivery arrangements for health systems in low‐income countries: an overview of systematic reviews
  232. Dengzhanhua preparations for acute cerebral infarction
  233. Diaries for recovery from critical illness
  234. Dietary advice for people with schizophrenia
  235. Dietary advice for reducing cardiovascular risk
  236. Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
  237. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
  238. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
  239. Dietary fibre for the primary prevention of cardiovascular disease
  240. Dietary flavonoid for preventing colorectal neoplasms
  241. Dietary interventions (plant sterols, stanols, omega‐3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia
  242. Dietary interventions for adult cancer survivors
  243. Dietary interventions for adults with chronic kidney disease
  244. Dietary interventions for mineral and bone disorder in people with chronic kidney disease
  245. Dietary interventions for multiple sclerosis‐related outcomes
  246. Dietary interventions for preventing complications in idiopathic hypercalciuria
  247. Dietary interventions for recurrent abdominal pain in childhood
  248. Dietary interventions for rheumatoid arthritis
  249. Dietary marine fatty acids (fish oil) for asthma in adults and children
  250. Dietary sodium manipulation and asthma
  251. Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes
  252. Dietary supplements for chronic gout
  253. Dietary supplements for dysmenorrhoea
  254. Dietary supplements for established atopic eczema
  255. Different types of dietary advice for women with gestational diabetes mellitus
  256. Drama therapy for schizophrenia or schizophrenia‐like illnesses
  257. Drug therapy for treating post‐dural puncture headache
  258. Drugs for preventing lung cancer in healthy people
  259. Early intervention for psychosis
  260. Early skin‐to‐skin contact for mothers and their healthy newborn infants
  261. Echinacea for preventing and treating the common cold
  262. Effect of cocoa on blood pressure
  263. Effects and safety of periconceptional oral folate supplementation for preventing birth defects
  264. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
  265. Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age
  266. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes
  267. Effects of total fat intake on body fatness in adults
  268. Effects of total fat intake on body weight
  269. Effects of total fat intake on bodyweight in children
  270. Eicosapentaenoic acid (EPA, an omega‐3 fatty acid from fish oils) for the treatment of cancer cachexia
  271. Electrical stimulation for faecal incontinence in adults
  272. Electrical stimulation for preventing and treating post‐stroke shoulder pain
  273. Electrical stimulation for the treatment of rheumatoid arthritis
  274. Electrical stimulation for treating pressure ulcers
  275. Electrical stimulation with non‐implanted devices for stress urinary incontinence in women
  276. Electrical stimulation with non‐implanted electrodes for overactive bladder in adults
  277. Electrical stimulation with non‐implanted electrodes for urinary incontinence in men
  278. Electromagnetic fields for treating osteoarthritis
  279. Electromagnetic therapy for treating pressure ulcers
  280. Electromagnetic therapy for treating venous leg ulcers
  281. Electrotherapy modalities for adhesive capsulitis (frozen shoulder)
  282. Electrotherapy modalities for rotator cuff disease
  283. Endometriosis: an overview of Cochrane Reviews
  284. Enteral nutrition for maintenance of remission in Crohn's disease
  285. Environmental enrichment for stroke and other non‐progressive brain injury
  286. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
  287. Exercise for dysmenorrhoea
  288. Exercise for preventing falls in older people living in the community
  289. Exercise for rheumatoid arthritis of the hand
  290. Exercise programs for people with dementia
  291. Exercises for mechanical neck disorders
  292. Fermented milk for hypertension
  293. Feverfew for preventing migraine
  294. Fish oil for induction of remission in ulcerative colitis
  295. Fish oil for kidney transplant recipients
  296. Flavonoids for treating venous leg ulcers
  297. Folate for depressive disorders
  298. Folate supplementation in people with sickle cell disease
  299. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
  300. Folic acid for fragile X syndrome
  301. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes
  302. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
  303. Galantamine for dementia in people with Down syndrome
  304. Ganoderma lucidum (Reishi mushroom) for cancer treatment
  305. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
  306. Garlic for peripheral arterial occlusive disease
  307. Garlic for preventing pre‐eclampsia and its complications
  308. Garlic for the common cold
  309. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
  310. Ginkgo biloba extract for age‐related macular degeneration
  311. Ginkgo biloba for acute ischaemic stroke
  312. Ginkgo biloba for cognitive impairment and dementia
  313. Ginkgo biloba for intermittent claudication
  314. Ginkgo biloba for tinnitus
  315. Ginseng for cognition
  316. Ginseng for erectile dysfunction
  317. Glucosamine therapy for treating osteoarthritis
  318. Glutamine for induction of remission in Crohn's disease
  319. Glutamine supplementation for critically ill adults
  320. Glutamine supplementation for young infants with severe gastrointestinal disease
  321. Glutamine supplementation to prevent morbidity and mortality in preterm infants
  322. Green and black tea for the primary prevention of cardiovascular disease
  323. Green tea (Camellia sinensis) for the prevention of cancer
  324. Green tea for weight loss and weight maintenance in overweight or obese adults
  325. Guided imagery for treating hypertension in pregnancy
  326. Hawthorn extract for treating chronic heart failure
  327. Helminth therapy (worms) for allergic rhinitis
  328. Helminth therapy (worms) for induction of remission in inflammatory bowel disease
  329. Herbal interventions for chronic asthma in adults and children
  330. Herbal medicinal products or preparations for neuropathic pain
  331. Herbal medicine for low‐back pain
  332. Herbal medicines for fatty liver diseases
  333. Herbal medicines for treating HIV infection and AIDS
  334. Herbal medicines for treatment of irritable bowel syndrome
  335. Herbal preparations for uterine fibroids
  336. Herbal therapy for treating rheumatoid arthritis
  337. High versus low‐added sugar consumption for the primary prevention of cardiovascular disease
  338. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
  339. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
  340. Homeopathy for chronic asthma
  341. Homeopathy for dementia
  342. Homeopathy for treatment of irritable bowel syndrome
  343. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
  344. Homocysteine‐lowering interventions for preventing cardiovascular events
  345. Honey and lozenges for children with non‐specific cough
  346. Honey as a topical treatment for wounds
  347. Honey for acute cough in children
  348. Horse chestnut seed extract for chronic venous insufficiency
  349. Horticultural therapy for schizophrenia
  350. Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace
  351. Humour‐based interventions for people with schizophrenia
  352. Huperzine A for Alzheimer's disease
  353. Huperzine A for mild cognitive impairment
  354. Huperzine A for vascular dementia
  355. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
  356. Hyperbaric oxygen therapy for acute ischaemic stroke
  357. Hyperbaric oxygen therapy for Bell's palsy
  358. Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury
  359. Hyperbaric oxygen therapy for multiple sclerosis
  360. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD)
  361. Hyperbaric oxygen therapy for promoting fracture healing and treating fracture non‐union
  362. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
  363. Hyperbaric oxygen therapy for vascular dementia
  364. Hyperbaric oxygenation for tumour sensitisation to radiotherapy
  365. Hypnosis for induction of labour
  366. Hypnosis for pain management during labour and childbirth
  367. Hypnosis for schizophrenia
  368. Hypnotherapy for smoking cessation
  369. Hypnotherapy for treatment of irritable bowel syndrome
  370. Immersion in water during labour and birth
  371. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases
  372. Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis
  373. Inositol for depressive disorders
  374. Inositol for subfertile women with polycystic ovary syndrome
  375. Intercessory prayer for the alleviation of ill health
  376. Intermittent fasting for the prevention of cardiovascular disease
  377. Intermittent oral iron supplementation during pregnancy
  378. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
  379. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews
  380. Interventions for apathy after traumatic brain injury
  381. Interventions for bullous pemphigoid
  382. Interventions for central serous chorioretinopathy: a network meta‐analysis
  383. Interventions for chronic kidney disease‐associated restless legs syndrome
  384. Interventions for chronic palmoplantar pustulosis
  385. Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy
  386. Interventions for cutaneous molluscum contagiosum
  387. Interventions for drug‐using offenders with co‐occurring mental health problems
  388. Interventions for dysarthria due to stroke and other adult‐acquired, non‐progressive brain injury
  389. Interventions for erosive lichen planus affecting mucosal sites
  390. Interventions for fatigue in inflammatory bowel disease
  391. Interventions for fatigue in peripheral neuropathy
  392. Interventions for fear of childbirth including tocophobia
  393. Interventions for heartburn in pregnancy
  394. Interventions for improving mobility after hip fracture surgery in adults
  395. Interventions for improving sleep quality in people with chronic kidney disease
  396. Interventions for improving upper limb function after stroke
  397. Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment
  398. Interventions for ingrowing toenails
  399. Interventions for itch in people with advanced chronic kidney disease
  400. Interventions for leg cramps in pregnancy
  401. Interventions for lowering plasma homocysteine levels in dialysis patients
  402. Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
  403. Interventions for managing asthma in pregnancy
  404. Interventions for managing taste disturbances
  405. Interventions for managing temporomandibular joint osteoarthritis
  406. Interventions for nausea and vomiting in early pregnancy
  407. Interventions for palliative symptom control in COVID‐19 patients
  408. Interventions for pityriasis rosea
  409. Interventions for post‐stroke fatigue
  410. Interventions for preventing and treating low‐back and pelvic pain during pregnancy
  411. Interventions for preventing bone disease in kidney transplant recipients
  412. Interventions for preventing falls in older people in care facilities and hospitals
  413. Interventions for preventing falls in older people living in the community
  414. Interventions for preventing falls in people after stroke
  415. Interventions for preventing infection in nephrotic syndrome
  416. Interventions for preventing mastitis after childbirth
  417. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section
  418. Interventions for preventing oral mucositis for patients with cancer receiving treatment
  419. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy
  420. Interventions for prevention of herpes simplex labialis (cold sores on the lips)
  421. Interventions for prevention of post‐operative recurrence of Crohn's disease
  422. Interventions for primary vesicoureteric reflux
  423. Interventions for prodromal stage of psychosis
  424. Interventions for reducing anxiety in women undergoing colposcopy
  425. Interventions for reducing inflammation in familial Mediterranean fever
  426. Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants
  427. Interventions for self‐harm in children and adolescents
  428. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
  429. Interventions for the management of abdominal pain in ulcerative colitis
  430. Interventions for the management of dry mouth: non‐pharmacological interventions
  431. Interventions for the management of oral submucous fibrosis
  432. Interventions for the reduction of prescribed opioid use in chronic non‐cancer pain
  433. Interventions for treating anxiety after stroke
  434. Interventions for treating burning mouth syndrome
  435. Interventions for treating collagenous colitis
  436. Interventions for treating constipation in pregnancy
  437. Interventions for treating constipation in pregnancy
  438. Interventions for treating gas gangrene
  439. Interventions for treating hyperemesis gravidarum
  440. Interventions for treating leg ulcers in people with sickle cell disease
  441. Interventions for treating oral leukoplakia to prevent oral cancer
  442. Interventions for treating painful nipples among breastfeeding women
  443. Interventions for treating persistent pain in survivors of torture
  444. Interventions for treating sexual dysfunction in patients with chronic kidney disease
  445. Interventions for treating urinary incontinence after stroke in adults
  446. Interventions for varicose veins and leg oedema in pregnancy
  447. Interventions to enhance return‐to‐work for cancer patients
  448. Interventions to facilitate return to work in adults with adjustment disorders
  449. Interventions to improve psychosocial well‐being in female BRCA‐mutation carriers following risk‐reducing surgery
  450. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews
  451. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
  452. Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews
  453. Iodine supplementation for women during the preconception, pregnancy and postpartum period
  454. Iron chelators for acute stroke
  455. Iron for the treatment of restless legs syndrome
  456. Iron supplementation for breath‐holding attacks in children
  457. Iron supplementation for reducing morbidity and mortality in children with HIV
  458. Isoflavones for hypercholesterolaemia in adults
  459. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
  460. Kava extract versus placebo for treating anxiety
  461. Ketogenic diets for drug‐resistant epilepsy
  462. L‐acetylcarnitine for treating fragile X syndrome
  463. L‐carnitine for cognitive enhancement in people without cognitive impairment
  464. L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
  465. Lactose avoidance for young children with acute diarrhoea
  466. Laetrile treatment for cancer
  467. Lecithin for dementia and cognitive impairment
  468. Lifestyle interventions for acute gout
  469. Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
  470. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
  471. Light therapy for non‐seasonal depression
  472. Light therapy for preventing seasonal affective disorder
  473. Lipid emulsions for parenterally fed preterm infants
  474. Lipid emulsions for parenterally fed term and late preterm infants
  475. Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes
  476. Local cooling for relieving pain from perineal trauma sustained during childbirth
  477. Long chain polyunsaturated fatty acid supplementation in infants born at term
  478. Low glycaemic index diets for the prevention of cardiovascular disease
  479. Low glycaemic index or low glycaemic load diets for overweight and obesity
  480. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
  481. Low protein diets for non‐diabetic adults with chronic kidney disease
  482. Low‐fat diets for acquired hypercholesterolaemia
  483. Lycopene for the prevention of prostate cancer
  484. Magnesium for alcohol withdrawal
  485. Magnesium for skeletal muscle cramps
  486. Magnesium for treating sickle cell disease
  487. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
  488. Magnesium supplementation for the management of primary hypertension in adults
  489. Magnesium supplementation in pregnancy
  490. Mailuoning for acute ischaemic stroke
  491. Management of gag reflex for patients undergoing dental treatment
  492. Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment
  493. Manipulative therapies for infantile colic
  494. Manual therapy and exercise for adhesive capsulitis (frozen shoulder)
  495. Manual therapy for asthma
  496. Massage and touch for dementia
  497. Massage for low‐back pain
  498. Massage for mechanical neck disorders
  499. Massage for promoting growth and development of preterm and/or low birth‐weight infants
  500. Massage for promoting mental and physical health in typically developing infants under the age of six months
  501. Massage therapy for people with HIV/AIDS
  502. Massage therapy for preventing pressure ulcers
  503. Massage with or without aromatherapy for symptom relief in people with cancer
  504. Massage, reflexology and other manual methods for pain management in labour
  505. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child
  506. Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood
  507. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants
  508. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
  509. Medicinal herbs for hepatitis C virus infection
  510. Meditation for adults with haematological malignancies
  511. Meditation therapies for attention‐deficit/hyperactivity disorder (ADHD)
  512. Meditation therapy for anxiety disorders
  513. Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
  514. Melatonin and agomelatine for preventing seasonal affective disorder
  515. Melatonin as add‐on treatment for epilepsy
  516. Melatonin for non‐respiratory sleep disorders in visually impaired children
  517. Melatonin for preoperative and postoperative anxiety in adults
  518. Melatonin for the prevention and treatment of jet lag
  519. Melatonin for the promotion of sleep in adults in the intensive care unit
  520. Melatonin for the treatment of dementia
  521. Melatonin for women in pregnancy for neuroprotection of the fetus
  522. Memantine for dementia in people with Down syndrome
  523. Methods of milk expression for lactating women
  524. Methods of preventing bacterial sepsis and wound complications after liver transplantation
  525. Micronutrient supplementation in adults with HIV infection
  526. Micronutrient supplementation in pregnant women with HIV infection
  527. Midwife‐led continuity models versus other models of care for childbearing women
  528. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
  529. Mind and body therapy for fibromyalgia
  530. Mind‐body interventions during pregnancy for preventing or treating women's anxiety
  531. Mindfulness‐based interventions for substance use disorders
  532. Mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors
  533. Mindfulness‐based stress reduction for family carers of people with dementia
  534. Mindfulness‐based stress reduction for women diagnosed with breast cancer
  535. Mistletoe therapy in oncology
  536. Momordica charantia for type 2 diabetes mellitus
  537. Monosodium glutamate avoidance for chronic asthma in adults and children
  538. Morita therapy for anxiety disorders in adults
  539. Morita therapy for schizophrenia
  540. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer
  541. Multinutrient fortification of human breast milk for preterm infants following hospital discharge
  542. Muscle energy technique for non‐specific low‐back pain
  543. Music during caesarean section under regional anaesthesia for improving maternal and infant outcomes
  544. Music for insomnia in adults
  545. Music for stress and anxiety reduction in coronary heart disease patients
  546. Music interventions for acquired brain injury
  547. Music interventions for improving psychological and physical outcomes in people with cancer
  548. Music interventions for mechanically ventilated patients
  549. Music interventions for preoperative anxiety
  550. Music therapy for depression
  551. Music therapy for people with autism spectrum disorder
  552. Music therapy for people with schizophrenia and schizophrenia‐like disorders
  553. Music‐based therapeutic interventions for people with dementia
  554. N‐acetylcarnosine (NAC) drops for age‐related cataract
  555. N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
  556. N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
  557. Neuraminidase inhibitors for preventing and treating influenza in adults and children
  558. Neuromodulators for pain management in rheumatoid arthritis
  559. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome
  560. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
  561. Neuromuscular electrical stimulation for the prevention of venous thromboembolism
  562. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
  563. Niacin for primary and secondary prevention of cardiovascular events
  564. Nicobrevin for smoking cessation
  565. Nicotine for schizophrenia
  566. Nidotherapy for people with schizophrenia
  567. Non surgical therapy for anal fissure
  568. Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
  569. Non‐clinical interventions for reducing unnecessary caesarean section
  570. Non‐drug therapies for the secondary prevention of lower limb muscle cramps
  571. Non‐hormonal interventions for hot flushes in women with a history of breast cancer
  572. Non‐invasive brain stimulation techniques for chronic pain
  573. Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
  574. Non‐pharmacological interventions for alleviating pain during orthodontic treatment
  575. Non‐pharmacological interventions for chronic pain in multiple sclerosis
  576. Non‐pharmacological interventions for chronic pain in people with spinal cord injury
  577. Non‐pharmacological interventions for cognitive impairment due to systemic cancer treatment
  578. Non‐pharmacological interventions for depression in adults and children with traumatic brain injury
  579. Non‐pharmacological interventions for fatigue in rheumatoid arthritis
  580. Non‐pharmacological interventions for people with epilepsy and intellectual disabilities
  581. Non‐pharmacological interventions for sleep promotion in the intensive care unit
  582. Non‐pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults
  583. Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain injury
  584. Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain injury
  585. Non‐surgical interventions for the management of chronic pelvic pain
  586. Non‐surgical treatment (other than steroid injection) for carpal tunnel syndrome
  587. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache
  588. Nut consumption for the primary prevention of cardiovascular disease
  589. Nutritional interventions for liver‐transplanted patients
  590. Nutritional interventions for preventing and treating pressure ulcers
  591. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy
  592. Nutritional interventions for reducing morbidity and mortality in people with HIV
  593. Nutritional interventions for survivors of childhood cancer
  594. Nutritional interventions for treating foot ulcers in people with diabetes
  595. Nutritional supplementation for hip fracture aftercare in older people
  596. Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
  597. Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
  598. Nutritional supplementation for stable chronic obstructive pulmonary disease
  599. Nutritional supplements for patients being treated for active visceral leishmaniasis
  600. Nutritional supplements for people being treated for active tuberculosis
  601. Nutritional support for acute kidney injury
  602. Nutritional support for liver disease
  603. Omega 3 fatty acid for the prevention of cognitive decline and dementia
  604. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
  605. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis
  606. Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration
  607. Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease
  608. Omega‐3 fatty acid addition during pregnancy
  609. Omega‐3 fatty acid supplementation for cystic fibrosis
  610. Omega‐3 fatty acids for bipolar disorder
  611. Omega‐3 fatty acids for depression in adults
  612. Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
  613. Omega‐3 fatty acids for intermittent claudication
  614. Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
  615. Omega‐3 fatty acids for the treatment of dementia
  616. Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
  617. Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
  618. Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
  619. Oral evening primrose oil and borage oil for eczema
  620. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
  621. Oral herbal therapies for treating osteoarthritis
  622. Oral immunotherapy for milk allergy
  623. Oral protein‐based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis
  624. Oral traditional Chinese medication for adhesive small bowel obstruction
  625. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
  626. Oral zinc for arterial and venous leg ulcers
  627. Oral zinc for the prevention of hyperbilirubinaemia in neonates
  628. Oral zinc for treating diarrhoea in children
  629. Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates
  630. Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings
  631. Ozone therapy for treating foot ulcers in people with diabetes
  632. Padma 28 for intermittent claudication
  633. Pain management for women in labour: an overview of systematic reviews
  634. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment
  635. Pain‐relieving agents for infantile colic
  636. Pancreatic enzymes for chronic pancreatitis
  637. Parent‐infant psychotherapy for improving parental and infant mental health
  638. Parenteral versus oral iron therapy for adults and children with chronic kidney disease
  639. Participation in environmental enhancement and conservation activities for health and well‐being in adults: a review of quantitative and qualitative evidence
  640. Passiflora for anxiety disorder
  641. Pelargonium sidoides extract for treating acute respiratory tract infections
  642. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women
  643. Perceptions and experiences of labour companionship: a qualitative evidence synthesis
  644. Peri‐operative glycaemic control regimens for preventing surgical site infections in adults
  645. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  646. Pharmacological agents for adults with acute respiratory distress syndrome
  647. Pharmacological and mechanical interventions for labour induction in outpatient settings
  648. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
  649. Pharmacological interventions for borderline personality disorder
  650. Pharmacological interventions for clozapine‐induced hypersalivation
  651. Pharmacological interventions for cognitive decline in people with Down syndrome
  652. Pharmacological interventions for self‐harm in adults
  653. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
  654. Pharmacological interventions for somatoform disorders in adults
  655. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy
  656. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome
  657. Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
  658. Pharmacotherapies for cannabis dependence
  659. Pharmacotherapies for sleep disturbances in dementia
  660. Phlebotonics for haemorrhoids
  661. Phlebotonics for venous insufficiency
  662. Phototherapy for atopic eczema
  663. Phyllanthus species for chronic hepatitis B virus infection
  664. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
  665. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews
  666. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
  667. Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer
  668. Physical therapies for postural abnormalities in people with cystic fibrosis
  669. Physical therapy for Bell's palsy (idiopathic facial paralysis)
  670. Phytoestrogens for menopausal vasomotor symptoms
  671. Phytomedicines (medicines derived from plants) for sickle cell disease
  672. Pilates for low back pain
  673. Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
  674. Polyunsaturated fatty acid supplementation for schizophrenia
  675. Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy
  676. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
  677. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
  678. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
  679. Potassium supplementation for the management of primary hypertension in adults
  680. Prebiotics for the prevention of hyperbilirubinaemia in neonates
  681. Prebiotics in infants for prevention of allergy
  682. Prescribed hypocaloric nutrition support for critically‐ill adults
  683. Preventing occupational stress in healthcare workers
  684. Prevention of depression in adults with long‐term physical conditions
  685. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
  686. Probiotics for induction of remission in Crohn's disease
  687. Probiotics for induction of remission in ulcerative colitis
  688. Probiotics for maintenance of remission in ulcerative colitis
  689. Probiotics for people with cystic fibrosis
  690. Probiotics for people with hepatic encephalopathy
  691. Probiotics for preventing acute otitis media in children
  692. Probiotics for preventing acute upper respiratory tract infections
  693. Probiotics for preventing gestational diabetes
  694. Probiotics for preventing preterm labour
  695. Probiotics for preventing urinary tract infection in people with neuropathic bladder
  696. Probiotics for preventing urinary tract infections in adults and children
  697. Probiotics for preventing ventilator‐associated pneumonia
  698. Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children
  699. Probiotics for the prevention of pediatric antibiotic‐associated diarrhea
  700. Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer
  701. Probiotics for the treatment of bacterial vaginosis
  702. Probiotics for treating acute infectious diarrhoea
  703. Probiotics for treating eczema
  704. Probiotics for treating persistent diarrhoea in children
  705. Probiotics for treatment of Clostridium difficile‐associated colitis in adults
  706. Probiotics for vulvovaginal candidiasis in non‐pregnant women
  707. Probiotics in infants for prevention of allergic disease and food hypersensitivity
  708. Probiotics to prevent infantile colic
  709. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
  710. Procaine treatments for cognition and dementia
  711. Prolotherapy injections for chronic low‐back pain
  712. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants
  713. Protein restriction for children with chronic kidney disease
  714. Protein restriction for diabetic renal disease
  715. Provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults
  716. Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
  717. Psychological and behavioural treatments for adults with non‐epileptic attack disorder
  718. Psychological and educational interventions for atopic eczema in children
  719. Psychological interventions for acute pain after open heart surgery
  720. Psychological interventions for coronary heart disease
  721. Psychological interventions for needle‐related procedural pain and distress in children and adolescents
  722. Psychological interventions for people with hemophilia
  723. Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness
  724. Psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy
  725. Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes
  726. Psychological interventions to foster resilience in healthcare professionals
  727. Psychological interventions to foster resilience in healthcare students
  728. Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia
  729. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents
  730. Psychological therapies for children and adolescents exposed to trauma
  731. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis
  732. Psychological therapies for pathological and problem gambling
  733. Psychological therapies for people with borderline personality disorder
  734. Psychological therapies for people with borderline personality disorder
  735. Psychological therapies for preventing seasonal affective disorder
  736. Psychological therapies for the management of chronic and recurrent pain in children and adolescents
  737. Psychological therapies for the management of chronic pain (excluding headache) in adults
  738. Psychological therapies for the prevention of migraine in adults
  739. Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
  740. Psychological therapies for the treatment of post‐traumatic stress disorder in children and adolescents
  741. Psychological therapies for treatment‐resistant depression in adults
  742. Psychological therapies for women who experience intimate partner violence
  743. Psychological treatments for people with epilepsy
  744. Psychosocial group interventions to improve psychological well‐being in adults living with HIV
  745. Psychosocial interventions for conversion and dissociative disorders in adults
  746. Psychosocial interventions for preventing and treating depression in dialysis patients
  747. Psychosocial interventions for recurrent abdominal pain in childhood
  748. Psychosocial interventions for self‐harm in adults
  749. Psychosocial interventions for self‐harm in adults
  750. Puerarin for ischaemic stroke
  751. Pygeum africanum for benign prostatic hyperplasia
  752. Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes
  753. Qigong for the primary prevention of cardiovascular disease
  754. Quinine for muscle cramps
  755. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
  756. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B
  757. Reduced dietary salt for the prevention of cardiovascular disease
  758. Reduced or modified dietary fat for preventing cardiovascular disease
  759. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy
  760. Reduction in saturated fat intake for cardiovascular disease
  761. Regimens of vitamin D supplementation for women during pregnancy
  762. Rehabilitation following carpal tunnel release
  763. Reiki for depression and anxiety
  764. Relaxation for depression
  765. Relaxation for perimenopausal and postmenopausal symptoms
  766. Relaxation techniques for pain management in labour
  767. Relaxation therapies for the management of primary hypertension in adults
  768. Relaxation therapy for preventing and treating preterm labour
  769. Relief of pain due to uterine cramping/involution after birth
  770. Reminiscence therapy for dementia
  771. Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke
  772. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults
  773. Repetitive transcranial magnetic stimulation for improving function after stroke
  774. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease
  775. Repetitive transcranial magnetic stimulation for tinnitus
  776. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
  777. Resveratrol for adults with type 2 diabetes mellitus
  778. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
  779. Roselle for hypertension in adults
  780. Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
  781. Rutosides for prevention of post‐thrombotic syndrome
  782. Rutosides for treatment of post‐thrombotic syndrome
  783. S‐adenosyl methionine (SAMe) for depression in adults
  784. S‐adenosyl‐L‐methionine for alcoholic liver diseases
  785. S‐Adenosylmethionine for osteoarthritis of the knee or hip
  786. Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults
  787. Sanchi for acute ischaemic stroke
  788. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients
  789. Selenium for preventing cancer
  790. Selenium supplementation for asthma
  791. Selenium supplementation for critically ill adults
  792. Selenium supplementation for Hashimoto's thyroiditis
  793. Selenium supplementation for the primary prevention of cardiovascular disease
  794. Serenoa repens for benign prostatic hyperplasia
  795. Simulated presence therapy for dementia
  796. Singing as an adjunct therapy for children and adults with cystic fibrosis
  797. Singing for adults with chronic obstructive pulmonary disease
  798. Singing for children and adults with bronchiectasis
  799. Single dose oral ibuprofen plus caffeine for acute postoperative pain in adults
  800. Single herbal medicine for diabetic retinopathy
  801. Skin‐to‐skin care for procedural pain in neonates
  802. Smectite for acute infectious diarrhoea in children
  803. Snoezelen for dementia
  804. Souvenaid for Alzheimer's disease
  805. Speleotherapy for asthma
  806. Spinal manipulation for dysmenorrhoea
  807. Spinal manipulative therapy for acute low‐back pain
  808. Spinal manipulative therapy for chronic low‐back pain
  809. Spiritual and religious interventions for well‐being of adults in the terminal phase of disease
  810. Sports and games for post‐traumatic stress disorder (PTSD)
  811. St John's wort for major depression
  812. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age
  813. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting
  814. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates
  815. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants
  816. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
  817. Sweet potato for type 2 diabetes mellitus
  818. Tai Chi for chronic obstructive pulmonary disease (COPD)
  819. Tai chi for primary prevention of cardiovascular disease
  820. Tai Chi for rheumatoid arthritis
  821. Tea tree oil for Demodex blepharitis
  822. Therapeutic touch for anxiety disorders
  823. Therapeutic ultrasound for chronic low back pain
  824. Thermotherapy for treating rheumatoid arthritis
  825. Thermotherapy for treatment of osteoarthritis
  826. Thiamine for Alzheimer's disease
  827. Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
  828. 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression
  829. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
  830. Thymic peptides for treatment of cancer patients
  831. Tianma Gouteng Yin Formula for treating primary hypertension
  832. Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention
  833. Tongxinluo (Tong xin luo or Tong‐xin‐luo) capsule for unstable angina pectoris
  834. Tongxinluo capsule for acute stroke
  835. Topical capsaicin (high concentration) for chronic neuropathic pain in adults
  836. Topical capsaicin (low concentration) for chronic neuropathic pain in adults
  837. Topical herbal therapies for treating osteoarthritis
  838. Topical treatments for chronic plaque psoriasis
  839. Traditional Chinese herbal medicine for vascular dementia
  840. Traditional Chinese herbal products for stable angina
  841. Traditional Chinese Medicine herbs for stopping bleeding from haemorrhoids
  842. Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
  843. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke
  844. Transcranial magnetic stimulation (TMS) for schizophrenia
  845. Transcranial magnetic stimulation for the treatment of epilepsy
  846. Transcranial magnetic stimulation for the treatment of obsessive‐compulsive disorder
  847. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults
  848. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain
  849. Transcutaneous electrical nerve stimulation (TENS) for chronic pain ‐ an overview of Cochrane Reviews
  850. Transcutaneous Electrical Nerve Stimulation (TENS) for dementia
  851. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults
  852. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults
  853. Transcutaneous electrical nerve stimulation (TENS) for pain management in labour
  854. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease
  855. Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
  856. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand
  857. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low‐back pain
  858. Transcutaneous electrical nerve stimulation for acute pain
  859. Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
  860. Transcutaneous electrical stimulation (TES) for treatment of constipation in children
  861. Transcutaneous electrostimulation for osteoarthritis of the knee
  862. Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies)
  863. Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis
  864. Treatment for ataxia in multiple sclerosis
  865. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
  866. Treatment for mitochondrial disorders
  867. Treatment for osteoporosis in people with ß‐thalassaemia
  868. Treatment for postpolio syndrome
  869. Treatment for recurrent vulvovaginal candidiasis (thrush)
  870. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease
  871. Treatments for breast engorgement during lactation
  872. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
  873. Tryptophan and 5‐Hydroxytryptophan for depression
  874. Tyrosine supplementation for phenylketonuria
  875. Uterine massage for preventing postpartum haemorrhage
  876. Valerian for anxiety disorders
  877. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
  878. Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
  879. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
  880. Vitamin A for non‐measles pneumonia in children
  881. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
  882. Vitamin A for treating measles in children
  883. Vitamin A supplementation for postpartum women
  884. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
  885. Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
  886. Vitamin A supplements for reducing mother‐to‐child HIV transmission
  887. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
  888. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
  889. Vitamin B and its derivatives for diabetic kidney disease
  890. Vitamin B for treating peripheral neuropathy
  891. Vitamin B6 for cognition
  892. Vitamin B12 for cognition
  893. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy
  894. Vitamin C for asthma and exercise‐induced bronchoconstriction
  895. Vitamin C for preventing and treating pneumonia
  896. Vitamin C for preventing and treating tetanus
  897. Vitamin C for preventing and treating the common cold
  898. Vitamin C supplementation for prevention and treatment of pneumonia
  899. Vitamin C supplementation for the primary prevention of cardiovascular disease
  900. Vitamin C supplementation in pregnancy
  901. Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
  902. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
  903. Vitamin D compounds for people with chronic kidney disease not requiring dialysis
  904. Vitamin D compounds for people with chronic kidney disease requiring dialysis
  905. Vitamin D for the management of asthma
  906. Vitamin D for the management of multiple sclerosis
  907. Vitamin D for the treatment of chronic painful conditions in adults
  908. Vitamin D supplementation for chronic liver diseases in adults
  909. Vitamin D supplementation for cystic fibrosis
  910. Vitamin D supplementation for improving bone mineral density in children
  911. Vitamin D supplementation for preventing infections in children under five years of age
  912. Vitamin D supplementation for prevention of cancer in adults
  913. Vitamin D supplementation for prevention of mortality in adults
  914. Vitamin D supplementation for sickle cell disease
  915. Vitamin D supplementation for the treatment of COVID‐19: a living systematic review
  916. Vitamin D supplementation for women during pregnancy
  917. Vitamin E for Alzheimer's dementia and mild cognitive impairment
  918. Vitamin E for antipsychotic‐induced tardive dyskinesia
  919. Vitamin E for intermittent claudication
  920. Vitamin E supplementation in people with cystic fibrosis
  921. Vitamin E supplementation in pregnancy
  922. Vitamin K for improved anticoagulation control in patients receiving warfarin
  923. Vitamin K for the primary prevention of cardiovascular disease
  924. Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases
  925. Vitamin K supplementation for cystic fibrosis
  926. Vitamin supplementation for preventing miscarriage
  927. Vitamins C and E for asthma and exercise‐induced bronchoconstriction
  928. Vitamins for epilepsy
  929. Water for preventing urinary stones
  930. Water for wound cleansing
  931. Weight loss interventions for chronic asthma
  932. Wendan decoction (Traditional Chinese medicine) for schizophrenia
  933. Whole grain cereals for the primary or secondary prevention of cardiovascular disease
  934. Whole grain foods for the prevention of type 2 diabetes mellitus
  935. Workplace interventions for reducing sitting at work
  936. Workplace lighting for improving alertness and mood in daytime workers
  937. Wound cleansing for pressure ulcers
  938. Written emotional disclosure for asthma
  939. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
  940. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
  941. Xuebijing for paraquat poisoning
  942. Xylitol for preventing acute otitis media in children up to 12 years of age
  943. Xylitol‐containing products for preventing dental caries in children and adults
  944. Yizhi capsule for vascular dementia
  945. Yoga as part of a package of care versus non‐standard care for schizophrenia
  946. Yoga as part of a package of care versus standard care for schizophrenia
  947. Yoga for asthma
  948. Yoga for epilepsy
  949. Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with breast cancer
  950. Yoga for secondary prevention of coronary heart disease
  951. Yoga for stroke rehabilitation
  952. Yoga for the primary prevention of cardiovascular disease
  953. Yoga for treating urinary incontinence in women
  954. Yoga in addition to standard care for patients with haematological malignancies
  955. Yoga treatment for chronic non‐specific low back pain
  956. Yoga versus non‐standard care for schizophrenia
  957. Yoga versus standard care for schizophrenia
  958. Zhiling decoction for vascular dementia
  959. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
  960. Zinc supplementation for improving pregnancy and infant outcome
  961. Zinc supplementation for mental and motor development in children
  962. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
  963. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
  964. Zinc supplementation for tinnitus
  965. Zinc supplements for preventing otitis media
  966. Zinc supplements for treating thalassaemia and sickle cell disease

 

Cochrane complementary medicine-related protocols as of December 31 2021

  1. Abdominal massage for the treatment of constipation
  2. Acupoint stimulation for postoperative ileus following gastrointestinal surgery
  3. Acupuncture for (sub)acute non‐specific low‐back pain
  4. Acupuncture for chronic constipation
  5. Acupuncture for chronic neck pain
  6. Acupuncture for female subfertility
  7. Acupuncture for turning a breech baby in pregnancy
  8. Adjunctive Peony‐Glycyrrhiza Decoction for antipsychotic‐induced hyperprolactinemia
  9. Alpha‐lipoic acid for diabetic peripheral neuropathy
  10. Alpha‐lipoic acid for hypertension in adults
  11. Alternative prophylactic therapies (acupuncture and/or moxibustion) for reducing blood loss in the third stage of labour
  12. Animal‐assisted therapy for people with serious mental illness
  13. Animal‐assisted therapy, including animal‐assisted activities and resident animals, for improving quality of life in people with stroke
  14. Antioxidant supplementation for sickle cell disease
  15. Antioxidants for acute pancreatitis
  16. Ayurveda interventions for rheumatoid arthritis
  17. Behavioural therapies versus treatment as usual for depression
  18. Biofeedback for neck pain
  19. Calcium and vitamin D for increasing bone mineral density in premenopausal women
  20. Calcium supplementation for weight reduction in overweight or obese people
  21. Cannabis and cannabinoids for people with multiple sclerosis
  22. Carnitine supplements for people with chronic kidney disease requiring dialysis
  23. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions
  24. Chinese herbal medicine for advanced pancreatic cancer
  25. Chinese medicinal herbs for vaginal bleeding of medical abortion
  26. Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
  27. Citicoline (CDP‐choline) for traumatic brain injury
  28. Cognitive behavioural therapy and third wave approaches for anxiety and related disorders in older people
  29. Combined large neutral amino acid supplementation for phenylketonuria (PKU)
  30. Complementary and alternative therapies for shortening labour
  31. Cordyceps sinensis for hypertension in adults
  32. Coriolus versicolor mushroom for colorectal cancer treatment
  33. Cranberries for treating asymptomatic bacteriuria during pregnancy
  34. Curcuma longa (turmeric) or its active ingredients for osteoarthritis
  35. Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
  36. Different strains of probiotics for preventing morbidity and mortality in preterm infants: a network meta‐analysis
  37. EEG neurofeedback for executive functions in children with neurodevelopmental challenges
  38. Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease
  39. Electrotherapy modalities for lateral elbow pain
  40. Essential phospholipids for people with non‐alcoholic fatty liver disease
  41. Fecal microbiota transplantation for treatment of irritable bowel syndrome
  42. Fiber and bulking agents for the treatment of chronic constipation
  43. Fish oil supplements for the prevention and treatment of hypertension in adults
  44. Fish oil‐based lipid emulsions versus standard lipid emulsions for prevention of parenteral nutrition‐associated liver disease in children
  45. Fish oil‐based lipid emulsions versus standard lipid emulsions for treatment of parenteral nutrition‐associated liver disease in children
  46. Folate supplementation in women of reproductive age
  47. Ginkgo biloba for tinnitus
  48. Ginkgo biloba versus placebo for schizophrenia
  49. Ginseng for improving the quality of life in people with cancer
  50. Glycyrrhizin for chronic hepatitis B virus infection
  51. Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection
  52. Herbal (non‐Chinese) medicines for functional dyspepsia
  53. Herbal medicines for systemic lupus erythematosus
  54. Herbal medicines for the treatment of inflammatory bowel disease
  55. Herbal preparations for weight loss in adults
  56. Homeopathy for osteoarthritis
  57. Homeopathy for reducing blood loss in the third stage of labour
  58. Humanistic therapies versus other psychological therapies for depression
  59. Humanistic therapies versus treatment as usual for depression
  60. Hyperbaric oxygen therapy for persistent post‐concussion syndrome following mild traumatic brain injury
  61. Hypnosis for preventing preterm labour
  62. Interventions for helping people recognise early signs of recurrence in depression
  63. Ketogenic diet for primary brain and spinal cord tumours
  64. Lactoferrin for the post‐operative management of term neonates after gastrointestinal surgery
  65. Leeches (Hirudinea) for osteoarthritis
  66. Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk
  67. Magnetic seizure therapy for people with schizophrenia
  68. Manual therapy and exercise for lateral elbow pain
  69. Manual therapy with exercise for neck pain
  70. Marine oil supplements for rheumatoid arthritis
  71. Massage therapy for improving functional activity after stroke
  72. The McKenzie method for (sub)acute non‐specific low‐back pain
  73. The McKenzie method for chronic non‐specific low‐back pain
  74. Medicinal herbs for acute hepatitis B
  75. Meditation for the primary and secondary prevention of cardiovascular disease
  76. Melatonin for preventing pre‐eclampsia
  77. Melatonin for treating pre‐eclampsia
  78. Melatonin in cancer treatment
  79. Mind‐body movement therapies for Parkinson's disease
  80. Mindfulness for smoking cessation
  81. Mindfulness‐based interventions for adults with type 2 diabetes mellitus
  82. Mindfulness‐based parenting programmes for improving psychosocial outcomes in children from birth to age 18 and their parents
  83. Modified dietary fat intake for treatment of gallstone disease
  84. Moxibustion for stroke rehabilitation
  85. Music therapy for people with substance use disorders
  86. Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants
  87. Neuroaid for improving recovery after ischemic stroke
  88. Non‐drug conservative treatments for acute urinary retention after surgery in adults
  89. Non‐hormonal therapy for hot flushes in postmenopausal women
  90. Non‐invasive brain stimulation for improving cognitive function in people with dementia and mild cognitive impairment
  91. Non‐pharmacological and non‐surgical treatments for low back pain in adults: an overview of Cochrane Reviews
  92. Non‐pharmacological interventions for managing dental anxiety in children
  93. Omega‐3 fatty acid supplementation for depression in children and adolescents
  94. Open Dialogue for psychosis or severe mental illness
  95. Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections
  96. Participation of traditional, complementary and alternative health practitioners in conventional health systems in low‐ and middle‐income countries
  97. Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy
  98. Perioperative antioxidants for adults undergoing elective non‐cardiac surgery
  99. Pharmacological interventions for jet lag
  100. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews
  101. Physical interventions (orthoses, splints, exercise and manual therapy) for treating plantar heel pain
  102. Phytoestrogens in the treatment of postmenopausal osteoporosis
  103. Prebiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
  104. Preschool and school‐based mindfulness programmes for improving mental health and cognitive functioning in young people aged 3 to 18 years
  105. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection
  106. Probiotics for fibromyalgia
  107. Probiotics for the post‐operative management of term neonates after gastrointestinal surgery
  108. Probiotics for the prevention of Hirschsprung‐associated enterocolitis
  109. Probiotics for the treatment of irritable bowel syndrome in children
  110. Probiotics for treatment of chronic constipation in children
  111. Protein restriction for diabetic kidney disease
  112. Psychodynamic therapies versus treatment as usual for depression
  113. Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults
  114. Reflexology for treatment of constipation
  115. S‐adenosyl‐L‐methionine for people with alcoholic liver disease
  116. Saffron (adjunct) for people with schizophrenia who have antipsychotic‐induced metabolic syndrome
  117. Selenium supplementation during pregnancy for improving maternal and newborn outcomes
  118. Singing for people with Parkinson's disease
  119. Spiritual and religious interventions for adults with cancer and their carers: an overview of systematic reviews
  120. Synbiotics, prebiotics and probiotics for people with chronic kidney disease
  121. Synbiotics, prebiotics and probiotics for solid organ transplant recipients
  122. Tai Chi for hypertension
  123. Tai Chi for improving recovery after stroke
  124. Tai chi for schizophrenia
  125. Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders
  126. Topical herbal interventions for gingivitis
  127. Topical, light‐based, and complementary interventions for acne: an overview of systematic reviews
  128. Traditional Chinese medicinal herbs for condyloma acuminatum
  129. Transcranial laser therapy for acute ischemic stroke
  130. Transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain
  131. Vegan diet for adults with overweight or obesity
  132. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
  133. Vitamin A supplementation for prevention of mortality and morbidity in moderate and late preterm infants
  134. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid life
  135. Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
  136. Vitamin D for the management of chronic obstructive pulmonary disease
  137. Vitamin D for the treatment of inflammatory bowel disease
  138. Vitamin D with or without calcium for treating osteoporosis in postmenopausal women
  139. Vitamin K for the prevention and treatment of osteoporosis in post‐menopausal women
  140. Yoga for osteoarthritis of the hip or knee
  141. Yoga for schizophrenia
  142. Zinc for prevention and treatment of the common cold